BAXDELA

This brand name is authorized in United States

Active ingredients

The drug BAXDELA contains one active pharmaceutical ingredient (API):

1 Delafloxacin UNII N7V53U4U4T - DELAFLOXACIN MEGLUMINE
Delafloxacin inhibits bacterial topoisomerase IV and DNA gyrase (topoisomerase II), enzymes required for bacterial DNA replication, transcription, repair, and recombination. Read about Delafloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BAXDELA Tablet / Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 70842-101, 70842-102

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.